Mitochondrial dynamics and T cells immunity in cancer Authors: Xiaomei Li, Minghui Zhang, Yan Wang, Muhan Li, Tianzhen Wang, Xi Liu Published: 2026 ABSTRACT Mitochondria are dynamic organelles that continuously adapt their number, morphology, and subcellular distribution in response to physiological and pathological stimuli. This plasticity is governed by a set of highly coordinated processes—collectively termed mitochondrial dynamics—including fusion, fission, mitophagy, and transport. Mitochondrial dynamics are essential for regulating cellular energy metabolism, proliferation, differentiation, and migration. Accumulating evidence highlights the critical role of mitochondrial dynamics in anti-tumor immunity, while their dysregulation contributes to immune evasion in cancer. In this review, we systematically outline how mitochondrial dynamics regulate the key stages of the T-cell immune response—from activation and differentiation to tumor infiltration, and finally to effector-mediated recognition and elimination of cancer cells—and elucidate the multifaceted mechanisms by which tumor cells suppress T-cell immunity through the regulation of mitochondrial dynamics. We aim to provide readers with an integrated conceptual framework, point toward future directions for translating fundamental insights into novel “metabolism–immunity” combination therapies, and thereby offer a theoretical foundation and strategic perspective for overcoming current bottlenecks in tumor immunotherapy. Introduction Mitochondria are ubiquitous in eukaryotic cells and are recognized as the cell's “powerhouse” due to their role in bulk adenosine triphosphate (ATP) production through oxidative respiration [1]. These organelles exhibit remarkable plasticity in terms of number, size, shape, and subcellular localization, enabling cells to adapt to physiological or pathological cues. This adaptive process is referred to as mitochondrial dynamics [2]. Dysregulation of mitochondrial dynamics has been linked to human cancers. Beyond its involvement in cancer metastasis, drug resistance, and cancer stem cell survival, emerging research highlights the critical role of mitochondrial dynamics in cancer immunity [3,4]. T cell-mediated immunity, which enables the specific recognition and killing of tumor cells, represents a central pillar of anticancer immunity [5]. Consequently, augmenting T cell function constitutes a fundamental goal of cancer immunotherapy. Existing studies indicate that mitochondrial dynamics constitute an indispensable core regulatory module governing T cell activation, differentiation, and effector function. In the tumor microenvironment, dysregulated mitochondrial dynamics induced by cancer cells directly precipitate metabolic and functional abnormalities in T cells, serving as a key mechanism driving T cell exhaustion, tumor immune escape, and immunotherapy resistance. By synthesizing recent advances in the field, this review delineates the regulatory roles and underlying mechanisms of mitochondrial dynamics in T cell-mediated antitumor immunity, as well as the multifaceted strategies employed by tumor cells to suppress T-cell function via modulating mitochondrial dynamics. Mitochondrial dynamics and their regulation mechanisms Mitochondrial dynamics coordinate a series of interlinked processes—including biogenesis, fission, fusion, intracellular transport, mitophagy, and cristae remodeling. Research in recent years has begun to unravel the complex molecular machinery and key regulatory proteins that govern these dynamics [6,7]. Mitochondrial dynamics adhere to the principle of “form follows function”: under high-energy demand and stress, fusion predominates, forming interconnected networks to optimize energy production and enhance resilience; during proliferation, distribution, and quality control screening, fission dominates, facilitating intracellular dispersal and laying the groundwork for subsequent clearance. Mitophagy removes severely damaged or depolarized mitochondria, ensuring quality control, while intracellular transport precisely delivers mitochondria to local high-energy-demand sites, providing metabolic and signaling support. In this section, we summarize the principal mechanisms underlying the regulation of mitochondrial dynamics (Fig. 1).Fig. 1Mitochondrial Dynamics and Their Regulatory Mechanisms. A. Mitochondrial biogenesis is primarily initiated by environmental signals, such as elevated energy demand, through the transcriptional upregulation of relevant genes. It is widely established that peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) interacts with co-transcriptional factors, including nuclear respiratory factor 1/2 (NRF1/2), Yin Yang 1 (YY1), peroxisome proliferator-activated receptors (PPARs), and estrogen-related receptors (ERRs), to drive this process [[8], [9], [10]]. PGC-1α activation also enhances mitochondrial transcription factor A (TFAM) transcription, a key regulator of mtDNA replication and transcription [11]. B. Mitophagy: The PTEN-induced kinase 1 (PINK1)-Parkin pathway represents the most well-characterized mechanism for mitophagy. Upon mitochondrial damage, the binding of adenine nucleotide translocator (ANT) to translocase of inner mitochondrial membrane 44 (TIM44) inhibits the TIM23-mediated import of PINK1 into the mitochondrial matrix, preventing its degradation[39]. Consequently, PINK1 accumulates on outer mitochondrial membrane (OMM), where it undergoes autophosphorylation and activation with the assistance of the translocase of outer mitochondrial membrane (TOM) complex. Active PINK1 recruits and phosphorylates the E3 ubiquitin ligase Parkin, which subsequently ubiquitinates OMM proteins to tag the damaged organelle [[12], [13], [14]]. PINK1 further phosphorylates these ubiquitinated substrates [15]. The ubiquitin-labeled mitochondria are then recognized by autophagy adaptor proteins, leading to their encapsulation into autophagosomes and eventual degradation via lysosomes [[16], [17], [18], [19]]. C. Mitochondrial Cristae Remodeling is a highly dynamic process regulated by the coordinated interplay of optic atrophy 1 (OPA1), the mitochondrial contact site and cristae organizing system (MICOS) complex, and ATP synthase dimers. Oligomerization of OPA1 constricts crista junctions (CJs) and promotes ATP synthase dimerization. The latter induce positive curvature to shape cristae architecture, promoting lamellar formation at their tips. The MICOS complex interacts with sorting and assembly machinery to modulate CJ formation and mediate mitochondrial membrane contacts. Dysfunction of the MICOS complex, OPA1, or ATP synthase disrupts cristae biogenesis and shaping [[20], [21], [22], [23], [24], [25]]. D. Mitochondrial Fusion and Fission are essential dynamic processes for maintaining organelle function, with fusion typically associated with higher bioenergetic efficiency and fission reflecting lower energy states [26]. Fusion of two mitochondria initiates with outer membrane fusion mediated by mitofusin (MFN), followed by inner mitochondrial membrane (IMM) fusion via OPA1 interaction [[27], [28], [29]]. The calcineurin dephosphorylates dynamin-related protein 1 (Drp1), which translocate from the cytosol to the mitochondrial surface assisted by mitochondrial receptors (mitochondrial fission factor (MFF), mitochondrial dynamics proteins of 49 and 51 kDa (MID49/51), fission protein 1 (FIS1)). Dephosphorylated DRP1 oligomerizes to form a fission complex, driving mitochondrial membrane constriction [[30], [31], [32]]. E. Mitochondrial Transport is a highly regulated, multi-modal process vital for both physiological homeostasis and disease progression. Cellular stress induces ER calcium release and elevated cytosolic Ca2+, which acts as a critical trigger for mitochondrial transfer. Mitochondria are then translocated between neighboring cells via tunneling nanotubes (TNTs), microvesicles, and extrusion-internalization. Adjacent cells also form gap junction channels (GJCs) that transmit calcium and signaling molecules to further promote mitochondrial transfer [[33], [34], [35]]. Mitochondrial Dynamics and Their Regulatory Mechanisms. A. Mitochondrial biogenesis is primarily initiated by environmental signals, such as elevated energy demand, through the transcriptional upregulation of relevant genes. It is widely established that peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) interacts with co-transcriptional factors, including nuclear respiratory factor 1/2 (NRF1/2), Yin Yang 1 (YY1), peroxisome proliferator-activated receptors (PPARs), and estrogen-related receptors (ERRs), to drive this process [[8], [9], [10]]. PGC-1α activation also enhances mitochondrial transcription factor A (TFAM) transcription, a key regulator of mtDNA replication and transcription [11]. B. Mitophagy: The PTEN-induced kinase 1 (PINK1)-Parkin pathway represents the most well-characterized mechanism for mitophagy. Upon mitochondrial damage, the binding of adenine nucleotide translocator (ANT) to translocase of inner mitochondrial membrane 44 (TIM44) inhibits the TIM23-mediated import of PINK1 into the mitochondrial matrix, preventing its degradation[39]. Consequently, PINK1 accumulates on outer mitochondrial membrane (OMM), where it undergoes autophosphorylation and activation with the assistance of the translocase of outer mitochondrial membrane (TOM) complex. Active PINK1 recruits and phosphorylates the E3 ubiquitin ligase Parkin, which subsequently ubiquitinates OMM proteins to tag the damaged organelle [[12], [13], [14]]. PINK1 further phosphorylates these ubiquitinated substrates [15]. The ubiquitin-labeled mitochondria are then recognized by autophagy adaptor proteins, leading to their encapsulation into autophagosomes and eventual degradation via lysosomes [[16], [17], [18], [19]]. C. Mitochondrial Cristae Remodeling is a highly dynamic process regulated by the coordinated interplay of optic atrophy 1 (OPA1), the mitochondrial contact site and cristae organizing system (MICOS) complex, and ATP synthase dimers. Oligomerization of OPA1 constricts crista junctions (CJs) and promotes ATP synthase dimerization. The latter induce positive curvature to shape cristae architecture, promoting lamellar formation at their tips. The MICOS complex interacts with sorting and assembly machinery to modulate CJ formation and mediate mitochondrial membrane contacts. Dysfunction of the MICOS complex, OPA1, or ATP synthase disrupts cristae biogenesis and shaping [[20], [21], [22], [23], [24], [25]]. D. Mitochondrial Fusion and Fission are essential dynamic processes for maintaining organelle function, with fusion typically associated with higher bioenergetic efficiency and fission reflecting lower energy states [26]. Fusion of two mitochondria initiates with outer membrane fusion mediated by mitofusin (MFN), followed by inner mitochondrial membrane (IMM) fusion via OPA1 interaction [[27], [28], [29]]. The calcineurin dephosphorylates dynamin-related protein 1 (Drp1), which translocate from the cytosol to the mitochondrial surface assisted by mitochondrial receptors (mitochondrial fission factor (MFF), mitochondrial dynamics proteins of 49 and 51 kDa (MID49/51), fission protein 1 (FIS1)). Dephosphorylated DRP1 oligomerizes to form a fission complex, driving mitochondrial membrane constriction [[30], [31], [32]]. E. Mitochondrial Transport is a highly regulated, multi-modal process vital for both physiological homeostasis and disease progression. Cellular stress induces ER calcium release and elevated cytosolic Ca2+, which acts as a critical trigger for mitochondrial transfer. Mitochondria are then translocated between neighboring cells via tunneling nanotubes (TNTs), microvesicles, and extrusion-internalization. Adjacent cells also form gap junction channels (GJCs) that transmit calcium and signaling molecules to further promote mitochondrial transfer [[33], [34], [35]]. T cell immunity and mitochondrial dynamics in cancer T cell-mediated immunity constitutes a core component of the adaptive immune system and plays a pivotal role in the specific elimination of cancer cells. Mitochondria serve not only as the powerhouse of T cells but also as a dynamic regulatory hub for their fate decisions, tissue infiltration, and effector functions. This section systematically delineates how mitochondrial dynamics—through metabolic reprogramming, morphological remodeling, and signal integration—precisely orchestrate the entire process of T-cell activation, differentiation, and cytotoxic execution. It further reveals key mechanisms by which the tumor microenvironment disrupts mitochondrial homeostasis to drive T-cell dysfunction. Mitochondrial dynamics are central to T cell fate decisions The activation of naïve T cells depends on synergistic signals: initial antigen recognition by the T cell receptor (TCR), enhanced by costimulatory molecules [36]. Cytokines govern the terminal stage: interleukin-2 (IL-2) drives clonal expansion and functional differentiation of activated T cells, whereas IL-15 is essential for memory T cell survival, homeostasis, and generation [37]. These signals trigger a precise intracellular cascade that converts extracellular recognition into functional changes (Fig. 2).Fig. 2Mitochondrial Dynamics in T Cell Immunity. A TCR activation leads to the upregulation of CMTR1, which promotes the expression of mitochondrial fusion-facilitating genes via alternative splicing, thereby triggering mitochondrial fusion and elongation, and enhancing oxidative phosphorylation. B Activated T cells trigger endoplasmic reticulum Ca2+ release and regulate Drp1 through dual phosphorylation and dephosphorylation. Activated Drp1 translocates to mitochondria at the immune synapse, driving mitochondrial fission and cristae remodeling. This process shapes the local Ca2+ microenvironment, facilitates metabolic reprogramming, and further activates ERK signaling to promote IL-2 secretion, ultimately driving T cells to undergo rapid proliferation and differentiation into effector T cells, with energy metabolism dominated by aerobic glycolysis. C. IL-15 binds to the interleukin-15 receptor (IL-15R), thereby activating the JAK-STAT5 signaling pathway, which transcriptionally upregulates Liver Kinase B1 (LKB1). LKB1 then phosphorylates and activates Adenosine Monophosphate-activated Protein Kinase (AMPK). Activated AMPK further promotes the activation of PGC-1α, which translocates into the nucleus, binds to other transcription factors (TFs), upregulates OPA1 expression, and ultimately facilitates mitochondrial fusion, enhances oxidative phosphorylation levels, and drives cellular differentiation into memory T cells. Mitochondrial Dynamics in T Cell Immunity. A TCR activation leads to the upregulation of CMTR1, which promotes the expression of mitochondrial fusion-facilitating genes via alternative splicing, thereby triggering mitochondrial fusion and elongation, and enhancing oxidative phosphorylation. B Activated T cells trigger endoplasmic reticulum Ca2+ release and regulate Drp1 through dual phosphorylation and dephosphorylation. Activated Drp1 translocates to mitochondria at the immune synapse, driving mitochondrial fission and cristae remodeling. This process shapes the local Ca2+ microenvironment, facilitates metabolic reprogramming, and further activates ERK signaling to promote IL-2 secretion, ultimately driving T cells to undergo rapid proliferation and differentiation into effector T cells, with energy metabolism dominated by aerobic glycolysis. C. IL-15 binds to the interleukin-15 receptor (IL-15R), thereby activating the JAK-STAT5 signaling pathway, which transcriptionally upregulates Liver Kinase B1 (LKB1). LKB1 then phosphorylates and activates Adenosine Monophosphate-activated Protein Kinase (AMPK). Activated AMPK further promotes the activation of PGC-1α, which translocates into the nucleus, binds to other transcription factors (TFs), upregulates OPA1 expression, and ultimately facilitates mitochondrial fusion, enhances oxidative phosphorylation levels, and drives cellular differentiation into memory T cells. Metabolic reprogramming and mitochondrial dynamics in T cell activation The specific binding of the TCR and coreceptors (CD4 or CD8) to peptide-MHC complexes, together with the engagement of costimulatory signals, collectively constitutes the initial prerequisite for full T cell activation. Integrated multi-omics analysis delineates the regulatory network of T cell activation, revealing a temporal cascade defined by early phosphorylation events and delayed ribosome biogenesis coupled with mitochondrial activation [38]. Functional validation confirms the essential role of oxidative phosphorylation (OXPHOS), mediated by the mitochondrial enzyme cytochrome c oxidase heme A: farnesyltransferase (COX10), in driving T cell exit from quiescence, highlighting mitochondrial metabolic reprogramming as a prerequisite for activation [38]. Moreover, enhanced OXPHOS provides not only the energetic foundation for T cell activation but also contributes to signaling modulation through the production of reactive oxygen species (ROS), while concurrently supporting biosynthesis and antioxidant defenses, thereby driving T cells out of quiescence and into the proliferative state. Intriguingly, recent work has uncovered a novel epitranscriptomic mechanism that fine-tunes mitochondrial function to support this metabolic switch. A recent study indicated that RNA cap methyltransferase 1 (CMTR1) is induced in activated T cells, and CMTR1 directs the selective splicing of mitochondrial dynamics regulators toward pro-fusion protein isoforms by methylating the spliceosomal core component U2 small nuclear RNA (U2 snRNA). This epitranscriptomic mechanism ultimately drives mitochondrial elongation and enhances respiratory capacity to meet the metabolic demands of T cell activation [39]. T cells subsequently enter a state of proliferation and differentiation. Mitochondrial dynamics and metabolic switching in effector T cells Following T cell activation, the cells initiate proliferation and proceed to differentiate into effector T cells, and metabolism shifts from OXPHOS toward aerobic glycolysis. This transition coincides with increased mitochondrial biogenesis and fission, producing a fragmented network with simplified cristae that supports the biosynthetic and rapid effector functions of these cells [40]. The mitochondrial fission factor Drp1 is central to this remodeling, enabling spatiotemporal adaptation to activation cues [41]. TCR engagement rapidly elevates cytosolic calcium, triggering full Drp1 activation via calcineurin (CN)-mediated dephosphorylation of Ser637 [30] and mitogen-activated protein kinase (MAPK)-dependent phosphorylation of Ser616 [42]. Activated Drp1 then translocates mitochondria to the immune synapse periphery-peripheral supramolecular activation cluster (pSMAC) [43,44], where it drives fission and inner membrane cristae remodeling. The repositioned mitochondrial network dynamically regulates the local calcium microenvironment and facilitates metabolic reprogramming [45,46]. This regulated calcium flux subsequently activates ERK signaling and promotes IL-2 secretion [47]. Collectively, these coordinated actions provide biphasic support—signaling stabilization and bioenergetic supply—critical for assembling and sustaining the central supramolecular activation cluster (cSMAC), thereby ensuring integrated TCR signal transduction. Mitochondrial dynamics and survival of memory T cells Activated T cells can differentiate into quiescent, long-lived memory T cells endowed with stem-like plasticity. In contrast to their effector counterparts, memory T cells depend on OXPHOS for survival—a metabolic mode sustained by fused mitochondrial networks that facilitate catabolic metabolism [47]. During this transition, OPA1 (rather than MFN1/2) plays a key role in maintaining cristae integrity and supporting OXPHOS activity, underscoring the essential contribution of cristae dynamics to the memory T cell phenotype [47]. This program can be initiated by metabolic cues, as glucose limitation upregulates OPA1 via adenosine monophosphate-activated protein kinase (AMPK), thereby promoting T cell survival and even regulatory T cell (Treg) development [48]. Conversely, impairing mitochondrial fission through Drp1 knockout promotes a memory-like transition [45]. Others, such as enhancing mitochondrial biogenesis or impairing autophagy, directly increase mitochondrial mass and promote memory T cell generation [49,50]. In summary, mitochondrial dynamics serve as a central hub linking extracellular signals to cell fate decisions in T cells. The morphological shift from fusion to fission precisely matches the metabolic demands for rapid biosynthesis and robust cytokine secretion during the transition from quiescence through activation to effector differentiation. Conversely, the reversal from fission back to fusion fulfills the intrinsic requirements of memory T cells for metabolic efficiency and long-term homeostasis, fully embodying the biological principle of organelle structure–function coupling. Mitochondrial dynamics regulate the infiltration of T cells The trafficking and infiltration of T cells into tumor tissues are essential steps for effective antitumor immunity, relying on continuous cytoskeletal rearrangement and energy supply—processes finely tuned by mitochondrial dynamics. Chemokine binding to cognate receptors activates the MAPK/ERK pathway, leading to ERK-mediated phosphorylation of Drp1 at Ser616, which enhances its fission activity [51,52]. This chemokine–ERK–Drp1 axis (e.g., via CCL21) is critical for T cell migration: Drp1 deficiency disrupts mitochondrial fission and impairs immune surveillance, whereas DRP1 overexpression promotes CD8+T cell infiltration into tumors and can even synergize with PD-1-targeted immunotherapy [42,53]. Upon activation, Drp1 shifts mitochondria from a fused network to a fragmented state. The resulting smaller mitochondria are rapidly transported by motor proteins (kinesin/dynein) along microtubules and accumulate at the uropod [54,55]. This fission-dependent redistribution supports migration through multiple mechanisms: it provides localized ATP for pseudopod extension and uropod contraction, regulates Rho-family GTPases via mitochondrial ROS, and maintains calcium homeostasis, thereby stabilizing polarity and enabling persistent migration through the extracellular matrix [56,57]. Notably, adequate mitochondrial mass and function are indispensable for infiltration. For instance, oxymatrine enhances CD4+ and CD8+T cell infiltration in triple-negative breast cancer by promoting mitochondrial biogenesis, respiratory activity, and cristae remodeling [57]. Mitochondrial fission is a prerequisite for T cell migration. Although fission is generally associated with glycolytic metabolic reprogramming, the repositioned mitochondria during migration still primarily rely on OXPHOS to meet the high energy demands of cytoskeletal remodeling. Thus, changes in mitochondrial dynamics do not simply replace one metabolic mode with another; rather, they optimize the local energy supply efficiency of OXPHOS through spatial reorganization. Mitochondrial dynamics regulates T cell effector function Upon recognition of tumor antigens, TCR signaling is rapidly activated, which in turn triggers the post-translational activation of the fission protein Drp1 through downstream signaling cascades, rather than transcriptional upregulation mediated by transcription factors such as NFAT, NF-κB, and AP-1 [58]. During this process, activated Drp1 translocates to the outer mitochondrial membrane and drives mitochondrial fission, shifting the mitochondrial network from an elongated, tubular morphology to a fragmented, short-rod phenotype, accompanied by mitochondrial cristae remodeling [40]. These smaller, highly mobile mitochondria are then rapidly trafficked along the cytoskeleton to the immune synapse, where they provide localized and efficient energy support for T cell cytotoxic functions [43,59]. Metabolically, activated T cells switch to a hybrid metabolic state dominated by aerobic glycolysis, supplemented by moderate OXPHOS and fatty acid oxidation (FAO) [60]. This activation phase is also characterized by the generation of moderate levels of mtROS, which act as second messengers to amplify TCR activation signals. Additionally, mitophagy is induced to clear damaged mitochondria, thereby maintaining mitochondrial homeostasis and ensuring sustained T cell function. However, persistent antigen exposure in the tumor microenvironment sustains Akt activation, which depletes PGC-1α and progressively impairs mitochondrial mass and function in tumor-specific T cells, ultimately compromising their cytotoxic capacity [61]. In this context, costimulatory signals, such as those delivered through CD137 (4-1BB), engage the p38-MAPK/PGC-1α pathway to enhance mitochondrial function from a complementary perspective: they improve OXPHOS efficiency, promote mitochondrial biogenesis, and increase metabolic flexibility, thereby sustaining the antitumor capacity of CD8+ T cells [62,63]. Mitophagy serves as a critical quality-control mechanism in sustaining the antitumor efficacy of T cells. Through canonical pathways such as PINK1/Parkin and BNIP3/NIX, mitophagy plays a central role in clearing damaged mitochondria, regulating cellular metabolism, and modulating signal transduction, thereby directly supporting T cell cytotoxic functions and cytokine secretion [60,64,65]. In summary, T cell effector function is driven by rapid mitochondrial fission, a process that enables metabolic reprogramming and provides local energy for the immune synapse. However, sustaining this response and preventing functional exhaustion require the ​coordinated involvement of mitochondrial fusion and mitophagy. This tripartite equilibrium ensures that T cells can maintain their anti-tumor capacity without succumbing to burnout, highlighting the critical balance between effector potency and long-term cellular durability. Tumor cells suppress T cell immunity by regulating mitochondrial dynamics In the tumor microenvironment, persistent antigen stimulation, dysregulated immune checkpoint signaling, and metabolic stress collectively disrupt mitochondrial biogenesis, fission–fusion dynamics, and mitophagy in T cells. This leads to structural abnormalities and impaired oxidative phosphorylation, resulting in energy failure and T cell exhaustion. Meanwhile, tumor cells achieve bidirectional mitochondrial transfer, delivering their own damaged mitochondria to T cells while sequestering healthy mitochondria from them. These processes coordinately suppress T cell immune function at both metabolic and organelle levels, ultimately promoting tumor immune escape (Fig. 3).Fig. 3Tumor Cell-Induced Immunosuppression via T Cell Mitochondrial Dysfunction Persistent antigen stimulation, immune checkpoint signaling, and tumor microenvironmental metabolic stress—including hypoxia, lactic acidosis, adenosine, PGE2, and TGF-β—collectively disrupt mitochondrial dynamics, biogenesis and mitophagy in T cells. These signals suppress oxidative phosphorylation, induce a compensatory shift to aerobic glycolysis, and cause eventual glycolytic collapse, resulting in energy depletion and T cell exhaustion. Furthermore, tumor cells mediate bidirectional mitochondrial transfer by delivering damaged mitochondria into T cells and hijacking healthy ones from immune cells, thereby promoting tumor immune escape. Tumor Cell-Induced Immunosuppression via T Cell Mitochondrial Dysfunction Persistent antigen stimulation, immune checkpoint signaling, and tumor microenvironmental metabolic stress—including hypoxia, lactic acidosis, adenosine, PGE2, and TGF-β—collectively disrupt mitochondrial dynamics, biogenesis and mitophagy in T cells. These signals suppress oxidative phosphorylation, induce a compensatory shift to aerobic glycolysis, and cause eventual glycolytic collapse, resulting in energy depletion and T cell exhaustion. Furthermore, tumor cells mediate bidirectional mitochondrial transfer by delivering damaged mitochondria into T cells and hijacking healthy ones from immune cells, thereby promoting tumor immune escape. Persistent antigen stimulation induces mitochondrial overload in T Cells Persistent tumor antigen stimulation drives CD8+T cell exhaustion, a dysfunctional state critically mediated by mitochondrial overload. This overload manifests through multiple interconnected pathways. Firstly, chronic TCR signaling upregulates the transcription factor Blimp-1, which represses PGC-1α expression, thereby impairing mitochondrial biogenesis, disrupting dynamics, and leading to mitochondrial fragmentation and functional exhaustion [66]. Concurrently, persistent stimulation suppresses the E3 ubiquitin ligase KLHL6. Its downregulation releases inhibition on the PGAM5–Drp1 axis, causing excessive Drp1 activation, pathological mitochondrial fission, and consequent bioenergetic crisis with ROS accumulation, accelerating exhaustion [67]. Furthermore, within the tumor microenvironment, integrated signals from chronic TCR engagement, PD-1, and metabolic stress jointly suppress PINK1–Parkin-mediated mitophagy. This failure in quality control results in the accumulation of depolarized mitochondria, further dysregulating mitochondrial dynamics and promoting terminal exhaustion [68]. At the core of this dysfunction, persistent stimulation impairs ADP-coupled oxidative phosphorylation. The resulting deficit in ATP production restricts nucleotide triphosphate synthesis, blocks proliferation, and upregulates exhaustion-associated genes. Thus, chronic antigen stimulation induces a synergistic mitochondrial bioenergetic failure that drives T cell exhaustion at both metabolic and transcriptional levels [69]. Multiple signals impair T cell mitochondrial homeostasis and function Immune checkpoint signaling mediates endogenous mitochondrial damage in T Cells PD-1 signaling systematically undermines the functional foundation of T-cell mitochondria at multiple levels. At the dynamic level, it impedes the key phosphorylation of Drp1 by inhibiting the ERK1/2 and mTOR pathways, thereby suppressing mitochondrial fission. This disruption leads to defective mitophagy and the abnormal accumulation of dysfunctional mitochondria in PD-1+T cells [68,70,71]. At the structural and energetic level, PD-1 signaling causes “structural damage” and “functional uncoupling.” On one hand, it downregulates the cristae structural core proteins CHCHD3/10, impairing the structural basis for ATP synthesis. Paradoxically, this damage coincides with enhanced assembly of respiratory chain supercomplexes, creating a vicious cycle of inefficient energy production that fundamentally compromises CD8+T cell effector function [72]. Ultimately, these insults converge into metabolic collapse and altered cell fate, including mitochondrial depolarization and ROS burst via inhibition of PGC-1α [61,73], and the steering of exhausted T cells toward ferroptosis via GATA1-mediated suppression of PLPP1 [74]. Tumor microenvironmental factors and metabolic stress collectively disrupt mitochondrial structure and function In addition to checkpoints expressed by T cells themselves, inhibitory cytokines within the tumor microenvironment represent crucial exogenous signals that damage mitochondrial function. For example, tumor-derived TGF-β can bypass classical transcriptional regulation to directly inhibit the activity of mitochondrial complex V (ATP synthase) in T cells, inducing “metabolic paralysis” in CD4+T cells [75]. It can also downregulate PGC-1α, thereby suppressing tricarboxylic acid cycle metabolism [76]. Similarly, Meteorin-like protein (METRNL) in the tumor microenvironment can act on CD8+T cells via autocrine/paracrine pathways. By upregulating the E2F-PPARδ signaling pathway, it induces mitochondrial depolarization, reduces OXPHOS and compensatorily activates glycolysis, ultimately leading to bioenergetic exhaustion in CD8+T cells [77]. OXPHOS in T cells is compromised both functionally and structurally. Within T cells, the stabilized expression of hypoxia-inducible factor-1α (HIF-1α) plays a dual role: on one hand, it activates Pyruvate Dehydrogenase Kinase 1 (PDK1), blocking pyruvate entry into the tricarboxylic acid cycle and thereby suppressing OXPHOS at the metabolic flux level [78,79]; on the other hand, HIF-1α upregulates miR-24, which inhibits the Myc–Mfn1 axis, exacerbating mitochondrial fragmentation and undermining the structural foundation of OXPHOS [80]. Subsequently, the compensatory glycolytic capacity of T cells is also impaired, leading to a “dual energy suppression” dilemma. This arises from two aspects: firstly, tumor cells, driven by their own HIF-1α, undergo the Warburg effect, producing large amounts of lactic acid and creating an acidic microenvironment that directly inhibits polyphosphate kinase (PPK) in T cells, weakening their glycolytic capacity [61,81]; secondly, immunosuppressive molecules accumulated in the tumor microenvironment (such as adenosine and PGE2) act on T cell surface receptors, activating protein kinase A (PKA) and negatively regulating the mTORC1 pathway, further compromising their metabolic adaptability [[82], [83], [84]]. Concurrently with the collapse of energy metabolism, the exhaustion program is initiated. Dysfunctional, fragmented mitochondria generate excessive mROS, which persistently activate NFAT signaling, leading to the upregulation of key exhaustion-related transcription factors TOX and NR4A, and ultimately inducing the permanent expression of exhaustion-related genes [80,85]. In summary, the hypoxic tumor microenvironment, through multi-layered and synergistic actions from both intrinsic and extrinsic pathways, sequentially deprives CD8+T cells of their oxidative phosphorylation and glycolytic functions, induces mitochondrial damage, and ultimately drives them toward a terminally exhausted state through combined metabolic and signaling disruptions. Mitochondrial transfer from tumor cells further suppresses T cell immune function Mitochondria can be transferred between cells through multiple pathways—a process known as mitochondrial transfer—which plays a critical role in tumor immune regulation and disease progression. Mitochondria can be transferred between cells through multiple pathways—a process known as mitochondrial transfer—that plays a critical role in tumor immune regulation and disease progression. In the tumor microenvironment, cells establish a sophisticated mitochondrial transport network via tunneling nanotubes (TNTs), exosomes, and gap junction channels, enabling organelle-level intercellular trafficking that directly manipulates T cell fate [86]. Recent studies have revealed bidirectional mitochondrial exchange between tumor cells and T cells. On the one hand, tumor cells strategically transfer dysfunctional mitochondria carrying mutated mitochondrial DNA (mtDNA) and highly expressing the deubiquitinating enzyme USP30 into T cells via TNTs or extracellular vesicles. By inhibiting Parkin-mediated mitophagy, USP30 allows these mitochondria to evade degradation and gradually replace the endogenous mitochondrial pool in T cells (homotypic replacement), resulting in failed metabolic reprogramming, a sharp increase in ROS levels, and ultimately the induction of T cell senescence and functional exhaustion [87]. On the other hand, within the resource-scarce tumor microenvironment, tumor cells exhibit metabolic “predatory” behavior. They primarily form TNTs to directly seize healthy mitochondria with intact oxidative phosphorylation (OXPHOS) activity from CD8+ T cells and natural killer (NK) cells. This process causes metabolic impairment in immune cells, characterized by collapsed OXPHOS and markedly reduced secretion of effector cytokines such as IFN-γ. Meanwhile, tumor cells utilize the hijacked mitochondria to activate the cGAS–STING–type I interferon pathway, thereby enhancing their own metabolic plasticity and promoting lymph node colonization and metastasis [88]. Collectively, tumor cells both “dump” damaged mitochondria and “steal” functional ones, converting immune cells from attackers into energy suppliers—a subtle and highly efficient strategy by which tumors achieve immune evasion. Conclusions and perspectives Mitochondrial dynamics regulate mitochondrial functional homeostasis by controlling morphological changes, which in turn alter metabolic patterns, energy supply efficiency, and ROS levels, ultimately determining key T-cell biological processes such as activation, differentiation, migration, and effector function. In the tumor microenvironment, infiltrating T cells, under multiple pressures including persistent antigen stimulation, hypoxia, and immunosuppressive signals, are prone to mitochondrial dysfunction, structural fragmentation, and impaired quality control, thereby driving T-cell dysfunction or exhaustion. The recently discovered phenomenon of bidirectional mitochondrial transfer further reveals that tumor cells can not only “dump” dysfunctional mitochondria into T cells but also actively plunder healthy, fully functional mitochondria from T cells, constituting a dual attack that damages T cells from within while depriving them of resources externally. In this context, targeting mitochondrial dynamics has emerged as a crucial intervention strategy in tumor immunotherapy. Combining such approaches with existing immune checkpoint inhibitors holds promise for synergistically reversing T-cell exhaustion and enhancing anti-tumor immune responses. However, current research still faces several limitations. The precise mechanisms by which mitochondrial dynamics regulate T-cell immunity remain incompletely understood, and the mutual regulatory relationships between mitochondrial dynamics in T cells and tumor cells require further exploration. Moreover, existing studies are still insufficient in terms of spatiotemporal resolution and data on tumor microenvironmental interactions, leaving a series of key scientific questions unanswered. For example, how do metabolic reprogramming and mitochondrial dynamics intertwine to cooperatively regulate T-cell function? Do metabolic switching and mitochondrial remodeling occur synchronously in time and space? Furthermore, identifying signaling molecules that can sense extracellular metabolite fluctuations and couple them to mitochondrial dynamics in immune cells has become an important direction for future research in this field. Notably, mitochondrial research is gradually moving beyond the traditional view of mitochondria as mere “powerhouses,” and their central role as “immune signaling hubs” is increasingly recognized. Going forward, breaking down disciplinary boundaries and integrating multi-omics technologies with cutting-edge research methods will be key to deciphering the dynamic regulatory networks of mitochondria in determining T-cell fate. The ultimate goal is to translate mitochondrial biology into novel mitochondrial-targeted immunotherapeutic strategies that can overcome current clinical treatment bottlenecks. In summary, mitochondria have emerged as the core metabolic hub governing the survival and function of anti-tumor T cells. A deeper understanding of the regulatory mechanisms of T-cell mitochondrial dynamics, as well as the multi-layered strategies employed by tumors to disrupt T-cell mitochondria, not only advances our knowledge of tumor immune evasion mechanisms but also lays a solid theoretical foundation for developing next-generation “metabolism–immunity” combination therapies. Future research should focus on identifying immune-specific metabolic nodes and developing microenvironment-responsive precision delivery strategies, thereby rescuing T cells from metabolic collapse and rebuilding potent, durable anti-tumor immune responses. Ethics statement These issues are not applicable for this review. Declaration of generative AI and AI-assisted technologies in the manuscript preparation process All figures were created with BioRender.com. During the preparation of this work, the authors used DeepSeek to polish language and check grammar. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. CRediT authorship contribution statement Xiaomei Li: Writing – original draft. Minghui Zhang: Software. Yan Wang: Validation. Muhan Li: Software. Tianzhen Wang: Conceptualization, Writing – review & editing. Xi Liu: Writing – review & editing. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.